Evaluates hepatic mixture risks of PFASs in drinking water, suggesting RPF-based assessment may be more accurate.
This study evaluated the reliability and application of relative potency factors (RPFs) for assessing hepatic mixture risks of per- and polyfluoroalkyl substances (PFASs) in Korean finished drinking water. A total of 1254 finished water samples collected from 70 drinking water treatment plants between 2018 and 2024 were analyzed for eight PFAS compounds. Hepatic RPFs proposed by the National Institute for Public Health and the Environment (RIVM) were assessed using a structured scoring system and applied to estimate PFOA-equivalent mixture risks. Hazard quotients (HQs) based on hepatic toxicity reference doses were also calculated for comparison. PFAS concentrations generally declined over time, including PFOA from 0.0032 to 0.0014 μg/L, PFOS from 0.0008 to 0.0003 μg/L, and PFHxS from 0.0072 to 0.0004 μg/L between 2018 and 2024. The RPF-based method produced higher cumulative risk estimates than the individual toxicity-based approach, suggesting that single-compound HQs may underestimate risks from co-occurring PFASs. Although total risks were generally below the non-carcinogenic threshold of 1.0, the 95th percentile PFOA-equivalent risk for PFNA exceeded the individual threshold of 0.1. These findings support endpoint-specific RPF-based assessment for PFAS mixtures in drinking water.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: